Skip to main content
December 4, 2021
TheStreet home
TheStreet home
INVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search
Join AAP
Subscribe

Pharmaceuticals

Moderna vaccine Lead
INVESTING
MRNAPFEBNTX

Moderna Stock Climbs; FDA Seeks Rapid Review of Omicron Vaccines

Glaxo, IP and PetMed Poised to Go Higher
INVESTING
GSKLLYREGN

Glaxo-Vir Antibody Drug Appears Effective vs. Omicron, Cleared by UK

How Build-A-Bear Workshop Was Built Into a Multi-Million Dollar Company
INVESTING
BBWABUSBOX

5 Top Stock Gainers for Wednesday; Dow Falls on Omicron Variant Fears

Bristol-Myers Gears Up for Earnings as Activist Investor Looms
INVESTING
BMY

Bristol Myers Represents Attractive Opportunity, BofA Says

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
MARKETS
MRKPFE

Merck Stock Gains After FDA Panel Backs Covid Pill Treatment Approval

Chinese Cancer Drug Developer Akeso Banks On Pharma Tie-up In Race With Rivals Amid Record-setting Hong Kong IPO
Video
MRKREGN

Leading Drugmakers Respond to Omicron Variant: Latest From Merck, Regeneron

Moderna
INVESTING
MRNAPFEJNJ

Moderna Stock: Here's How to Trade It Amid the Omicron Variant

NYSE Stock Market Wall Street Trader
STOCKS
MRNAREGNIMGN

Dow Closes 650 Points Down on Omicron Fears, Hawkish Powell Testimony

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half
INVESTING
IMGNIBRXNVGS

5 Top Stock Gainers for Tuesday: ImmunoGen, Immunity Bio, Navigator

Under Armour Coronavirus Athletic Mask Lead
INVESTING
NLSP

NLS Pharmaceutics Soars on Long Covid Fatigue Test Results

AstraZeneca Lead
HEALTH
AZNMRK

AstraZeneca Gains Priorty FDA Review for Breast Cancer Drug

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint
MARKETS
IMGN

ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial

Merck Lead
HEALTH
MRK

Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel

Moderna vaccine Lead
MARKETS
MRNAREGNPFE

Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings

Wall Street Lead
JIM CRAMER
PFEMRNAAMZN

Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix

Network-Security Provider Zscaler Jumps on B of A Upgrade to Buy From Neutral
INVESTING
ZSRCLMRNA

5 Top Stock Gainers for Monday: Zscaler, Krystal Biotech, Adagio

Ready to Trade Bristol-Myers Squibb, Bank of America, CSX? Here's What to Know
INVESTING
BMYAMGN

Bristol Myers Stock Falls Despite Positive News on Psoriasis Drug

Pfizer Pill Lead
MARKETS
PFE

Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant

Pfizer BioNTech Moderna Lead
MARKETS
MRNAPFE

Moderna Stock Surges As Drugmaker Says It Can Have Omicron Vaccine Ready in Early 2022

New York Stock Exchange Lead
MARKETS
PFEMRNAMRK

Market Ends Down as Dow, Oil and Global Markets Feel Sting of New Covid Variant

Hong Kong Stock Market Sentiment Weighed Down By Rising Tensions Between Washington And Beijing
INVESTING
OXYCOINMRNA

Premarket Movers Friday: Fears of New Covid Variant Grip Markets

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
MARKETS
MRK

Merck Slides as Covid Pill Treatment Data Show Lower Efficacy

Pfizer BioNTech Moderna Lead
MARKETS
PFEMRNAMRK

Pfizer Stock Hits Record High, Moderna Surges On New Covid Variant Discovery

AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug
INVESTING
ABBVBMY

AbbVie Stock Rises on Upgrade to Buy from Hold by SocGen